Nyprax Pharma is a leading regulatory consultancy firm with over 30 years of experience supporting pharmaceutical, medical device, cosmetic, and health supplement companies across Singapore and Malaysia. The company provides end-to-end regulatory services, including product registration, independent licence holding, quality management systems, CMC and pharmacovigilance support, and compliance for GDPMDS and GDPMD. With more than 5,000 medical devices registered and over 500 companies represented, Nyprax Pharma is trusted for its accuracy, efficiency, and deep regulatory expertise. Guided by a commitment to professionalism, integrity, and client-focused solutions, the firm continues to be a reliable partner for businesses seeking seamless market access and regulatory approval in the region.